According to China media reports, Cambridge Capital has set up its second fund, Cambridge Medical Fund II, with an amount of US$ 400 million. The newly established fund and its first fund (20 14 closed at $200 million) focus on late-stage companies in biotechnology, pharmaceuticals, medical devices and health care.

CBridgeCapital is a private equity fund focusing on medical and health industry investment, mainly engaged in middle and late growth and M&A investment, covering medicine, medical devices, medical services and other major health fields. In the past few years, Kangqiao Capital has successfully completed investment projects covering medical and health sub-sectors such as biopharmaceuticals, drug circulation, molecular diagnosis and medical devices. Cambridge Capital aims to use the power of capital to accelerate the research and development and marketization of modern medical care and medical technology, improve the health level of the whole people and benefit mankind.